Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis
Open Access
- 1 April 1997
- Vol. 52 (Supplement) , S89-S91
- https://doi.org/10.1136/thx.52.2008.s89
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Evolution of Therapy for Cystic FibrosisNew England Journal of Medicine, 1994
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994
- Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosisThe Lancet, 1993
- Clinical management of pulmonary disease in cystic fibrosisThe Lancet, 1993
- How to get drugs into the respiratory tract.Archives of Disease in Childhood, 1993
- Efficacy of salbutamol and ipratropium bromide in decreasing bronchial hyperreactivity in children with cystic fibrosisPediatric Pulmonology, 1992
- Variability of pulmonary function tests in cystic fibrosisPediatric Pulmonology, 1990
- Longitudinal response of pulmonary function to bronchodilators in cystic fibrosisPediatric Pulmonology, 1990
- Anti-asthma drugs attenuate inflammatory leakage of plasma into airway lumenActa Physiologica Scandinavica, 1986
- The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosisThe Journal of Pediatrics, 1973